Artificial Intelligence and Heart Failure: A State-of-the-Art Review
European Journal of Heart Failure · 01.09.2023 · 25 (9) · 1507-1525
DOI: 10.1002/ejhf.2994 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Heart Failure, online erschienen am 08.09.2023. Verfasst von Muhammad Shahzeb Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Duke University School of Medicine, Durham, NC, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Heart Failure. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Themen: Künstliche Intelligenz in der Pflege, Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a heterogeneous syndrome affecting more than 60 million individuals globally. Despite recent advancements in understanding of the pathophysiology of HF, many issues remain including residual risk despite therapy, understanding the pathophysiology and phenotypes of patients with HF and preserved ejection fraction, and the challenges related to integrating a large amount of disparate information available for risk stratification and management of these patients. Risk prediction algorithms based on artificial intelligence (AI) may have superior predictive ability compared to traditional methods in certain instances. AI algorithms can play a pivotal role in the evolution of HF care by facilitating clinical decision making to overcome various challenges such as allocation of treatment to patients who are at highest risk or are more likely to benefit from therapies, prediction of adverse outcomes, and early identification of patients with subclinical disease or worsening HF. With the ability to integrate and synthesize large amounts of data with multidimensional interactions, AI algorithms can supply information with which physicians can improve their ability to make timely and better decisions. In this review, we provide an overview of the AI algorithms that have been developed for establishing early diagnosis of HF, phenotyping HF with preserved ejection fraction, and stratifying HF disease severity. This review also discusses the challenges in clinical deployment of AI algorithms in HF, and the potential path forward for developing future novel learning-based algorithms to improve HF care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
- Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
- Duke Clinical Research Institute, Durham, NC, USA.
- Department of Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
- Canada Population Health Research Institute, Hamilton, ON, Canada.
- Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Zitieren
APA
Khan, M. S., Arshad, M. S., Greene, S. J., Van Spall, H. G. C., Pandey, A., Vemulapalli, S., Perakslis, E., & Butler, J. (2023). Artificial Intelligence and Heart Failure: A State-of-the-Art Review. European Journal of Heart Failure, 25(9), 1507-1525. https://doi.org/10.1002/ejhf.2994
Vancouver
Khan MS, Arshad MS, Greene SJ, Van Spall HGC, Pandey A, Vemulapalli S, et al. Artificial Intelligence and Heart Failure: A State-of-the-Art Review. European Journal of Heart Failure. 2023;25(9):1507-1525. doi:10.1002/ejhf.2994
BibTeX
@article{Khan2023,
author = {Khan, Muhammad Shahzeb and Arshad, Muhammad Sameer and Greene, Stephen J and Van Spall, Harriette G C and Pandey, Ambarish and Vemulapalli, Sreekanth and Perakslis, Eric and Butler, Javed},
title = {Artificial Intelligence and Heart Failure: A State-of-the-Art Review},
journal = {European Journal of Heart Failure},
year = {2023},
volume = {25},
number = {9},
pages = {1507--1525},
doi = {10.1002/ejhf.2994}
}
EUVIMED